BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 10998107)

  • 1. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.
    Hájos N; Katona I; Naiem SS; MacKie K; Ledent C; Mody I; Freund TF
    Eur J Neurosci; 2000 Sep; 12(9):3239-49. PubMed ID: 10998107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
    Hájos N; Ledent C; Freund TF
    Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission.
    Katona I; Rancz EA; Acsady L; Ledent C; Mackie K; Hajos N; Freund TF
    J Neurosci; 2001 Dec; 21(23):9506-18. PubMed ID: 11717385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
    Hoffman AF; Riegel AC; Lupica CR
    Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
    Szabo B; Siemes S; Wallmichrath I
    Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.
    Diana MA; Levenes C; Mackie K; Marty A
    J Neurosci; 2002 Jan; 22(1):200-8. PubMed ID: 11756503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
    Takahashi KA; Linden DJ
    J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
    Hofmann ME; Bhatia C; Frazier CJ
    J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition.
    Hájos N; Freund TF
    Chem Phys Lipids; 2002 Dec; 121(1-2):73-82. PubMed ID: 12505692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons.
    Katona I; Sperlágh B; Sík A; Käfalvi A; Vizi ES; Mackie K; Freund TF
    J Neurosci; 1999 Jun; 19(11):4544-58. PubMed ID: 10341254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.
    Wilson RI; Nicoll RA
    Nature; 2001 Mar; 410(6828):588-92. PubMed ID: 11279497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
    Hájos N; Freund TF
    Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
    Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
    J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells.
    Holderith N; Németh B; Papp OI; Veres JM; Nagy GA; Hájos N
    J Physiol; 2011 Oct; 589(Pt 20):4921-34. PubMed ID: 21859823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells.
    Yoshida T; Hashimoto K; Zimmer A; Maejima T; Araishi K; Kano M
    J Neurosci; 2002 Mar; 22(5):1690-7. PubMed ID: 11880498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs.
    Lemtiri-Chlieh F; Levine ES
    J Neurophysiol; 2007 Nov; 98(5):2517-24. PubMed ID: 17881480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
    Kathmann M; Weber B; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
    Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
    Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.